Patient Monitoring Devices Market By Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices); By End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

$5,000$10,000

Patient Monitoring Devices Market to surpass USD 60.3 Billion by 2030 from USD 20.2 billion in 2018 in terms of value growing at a CAGR of 6.2% throughout the forecast period, i.e., 2019-30.

Clear

Description

Product Overview
Patient monitoring devices are a technology used to collect and electronically transmit medical and health-related data from individuals at one location to a healthcare provider at another location. Patient monitoring equipment continuously tracks patient’s vital health signs, such as respiratory rate, heart rate, and rhythm, blood pressure, a saturation of blood oxygen, and many other parameters. These devices assist in examining the health condition of a patient and provide healthcare professionals with timely warnings about the delivery of medical services to the patient. Continuous patient monitoring has been found to have enabled early detection of patient deterioration and early treatment. Besides, wearable patient monitoring systems have provided patients with wireless technology with freedom and comfort.

Market Highlights
Patient Monitoring Devices Market is expected to project a notable CAGR of 6.2% in 2030.
Patient Monitoring Devices Market to surpass USD 60.3 Billion by 2030 from USD 20.2 billion in 2018 in terms of value growing at a CAGR of 6.2% throughout the forecast period, i.e., 2019-30. A key trend in inpatient care is the integration of monitoring technologies into smartphones and wireless devices, leading to the introduction of remote monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, outpatient wireless EEG recorders, and outpatient event monitors, which are key factors that support market growth. The market has been accelerated by the change in lifestyle patterns and the increasing cases of chronic diseases among the global population. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period.

Patient Monitoring Devices Market: Segments
Cardiac Monitoring Devices Segment to grow with the highest CAGR during 2019-30
Patient Monitoring Devices Market is segmented by type as hemodynamic monitoring, neuromonitoring, cardiac monitoring, fetal & neonatal monitoring, respiratory monitoring, multi-parameter monitoring, remote patient monitoring, weight monitoring, and temperature monitoring devices. The cardiac monitoring devices segment is estimated to lead the market with a share of over 26.0% of in Patience monitoring device market in 2018 and this trend is expected to continue during the forecast period. This is attributed to an increase in the prevalence of different cardiovascular diseases throughout the world each year, such as congestive heart failure and stroke. The segment is rapidly gaining popularity among patients with chronic diseases such as diabetes, hypertension, and chronic respiratory diseases because remote patient monitoring devices can be used remotely to monitor critical parameters of patients. It is therefore expected to be the fastest-growing segment registering a CAGR of 6.7% during the forecast period.

The hospital Segment to grow with the highest CAGR during 2019-30
Patient Monitoring Devices Market is segmented by End-user into hospitals, ambulatory surgery centers, home care settings, and others. The Ambulatory surgical centers are emerged as the leading end-user segment in 2018 and accounted for over XX.X of the market share. During the forthcoming years, the ambulatory surgical centers’ segment is estimated to see around 6 percent growth. In developed economies, a large number of populations are inclined toward ASCs, as they are equipped with advanced patient monitoring devices and well-developed infrastructure. In ASCs, the conventional type of patient monitoring device is particularly preferred because it is cost-effective. Various advantages, such as the reduced risk of hospital-acquired infection, shorter hospital stay, and quality treatment, increase patient preference for ASCs, fostering the size of the market. The presence of advanced ICUs and emergency wards in hospitals and the increasing number of surgical procedures can primarily be attributed to significant market growth and a large share of the hospital segment.

Patient Monitoring Devices Market: Market Dynamics
Drivers
Rising Burden of Chronic Diseases
Chronic heart disease, diabetes, and chronic respiratory diseases are the world’s leading causes of mortality and morbidity. 75% of healthcare costs are accounted for by chronic care management. The rise in the prevalence of chronic circumstances places a huge financial burden on caregivers. It thus decreases readmissions and prevents hospitalizations that are avoidable. Besides, these technologies reduce the number of unnecessary trips to the doctor’s office and reduce the travel costs required to receive quality medical care. Therefore, it is expected that the increasing focus on a healthy lifestyle, the increasing trend of self-monitoring and preventive medicine, and the growing concern for constant monitoring of patient health parameters will drive the growth of the overall market.

Growing Preference for Home and Remote Monitoring
Due to the increasing prevalence of cardiovascular diseases worldwide, the cardiac monitoring devices segment valuation in 2019 was over USD 2.4 billion. Different surgical treatments are performed on a large population base suffering from cardiovascular diseases and require accurate monitoring of vital parameters affecting the market growth. Besides, manufacturers such as Medtronic have introduced technologically advanced products to obtain accurate information that further stimulates the expansion of the market for better patient care. A few applications for wearable patient monitoring devices, biosensors, and smart implants are continuous glucose monitoring, temperature monitoring, blood pressure monitoring, and pulse oximetry. The Internet of Things technology is equipped with new-generation wearable devices that increase remote monitoring.

Restrain
Risk associated with invasive monitoring devices
Several risks are associated with the use of invasive monitoring systems, such as discomfort associated with the insertion of monitoring tools, such as pulmonary artery catheters (PAC). Some other major risks are air embolism, sepsis, bleeding/hematoma formation, cardiac arrhythmias, decreased distal limb circulation, hemorrhage, damage to the nerves (during insertion), thrombosis, air embolism, and pulmonary capillary necrosis. The mortality rate during invasive procedures is increased by these factors. Consequently, the risks mentioned above limit the use of invasive monitoring devices.

Patient Monitoring Devices Market: Key Players
Abbott Laboratories
Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Aerotel Medical Systems
AMD Global Telemedicine
Baxter International Inc.
Boston Scientific Corporation
GE Healthcare
Masimo Corporation
Medtronic PLC
Omron Corporation
Patient Monitoring Devices Market: Regions
Patient Monitoring Devices Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.

Patient Monitoring Devices Market in North America led the market in 2018. The key factors supporting market growth in North America are increasing R&D to develop novel sensor-based patient monitoring systems, increasing infectious disease prevalence, safety concerns, and technological advances in patient monitoring device products. Besides, most of the world’s leading companies are headquartered in the region or have a strong presence in that market, another key factor that is attributed to the market’s significant growth. Europe, particularly Western European countries, is expected to remain the second most profitable region over the forecast period due to a higher mortality rate and rising demand for low-cost treatment. High-impact drivers for regional growth are increasing demand for in-house monitoring, supportive central data management systems, and increasing the accuracy and efficiency of remote patient monitoring systems.

Competitive Landscape:
The Patient Monitoring Devices market, which is highly competitive, consists of several major players such as Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany) hold a substantial market share in the Patient Monitoring Devices market. Other players analyzed in this report are Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (US), among others.

Key players are adopting inorganic growth strategies such as product launches in the global nutritional supplement market. For instance, In December 2019, Masimo Corporation received FDA approval for the Neonatal RD SET Pulse Oximetry Sensors. Clinical studies have shown that the use of these oximeters reduces severe retinopathy in neonates.

Patient Monitoring Devices Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA
Patient Monitoring Devices Market report also contains analysis on:
Patient Monitoring Devices Market Segments:

By Product:
Hemodynamic Monitoring Devices
Blood Glucose
Cholesterol
Blood Gas & Electrolyte Analyzers/Monitors
Blood Pressure
Neuromonitoring Devices
Electroencephalograph (EEG) Devices
Transcranial Dopplers (TCD)
Magnetoencephalography (MEG) Devices
Intracranial Pressure Monitors (ICP)
Cerebral Oximeters
Cardiac Monitoring Devices
Electrocardiogram (ECG) Devices
Holter Monitor
Event Monitors
Others
Fetal & Neonatal Monitoring Devices
Ultrasound
Electronic Fetal Monitoring Devices
Fetal Doppler Monitoring Devices
Other Fetal & Neonatal Monitoring Devices
Respiratory Monitoring Devices
Capnographs
Spirometers
Sleep Apnea Monitor
Pulse Oximeters
Multiparameter Monitoring Devices
High Acuity
Mid Acuity
Low Acuity
Remote Patient Monitoring Devices
Weight Monitoring Devices
Temperature Monitoring Devices
By End User:
Hospitals
Ambulatory Surgery Centers
Home Care Settings
Other
Patient Monitoring Devices Market Dynamics
Patient Monitoring Devices Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Patient Monitoring Devices Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Patient Monitoring Devices Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Patient Monitoring Devices Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Remote Patient Monitoring (RPM): Market Segmentation
12.1. By Regions
12.2. By Regions
12.2.1. North America:(U.S. and Canada)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Type: Market Share (2020-2030F)
12.2.1. Hemodynamic Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Neuromonitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Cardiac Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Fetal & Neonatal Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Respiratory Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.6. Multiparameter Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.7. Remote Patient Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.8. Weight Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.9. Temperature Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By End User: Market Share (2020-2030F)
12.3.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Ambulatory Surgery Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Home Care Settings, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.4. Other, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. Company Profile
13.1.1. Abbott Laboratories
13.1.2. Company Overview
13.1.3. Company Total Revenue (Financials)
13.1.4. Market Potential
13.1.5. Global Presence
13.1.6. Key Performance Indicators
13.1.7. SWOT Analysis
13.1.8. Product Launch
13.2. Aerotel Medical Systems
13.3. AMD Global Telemedicine
13.4. Baxter International Inc.
13.5. Boston Scientific Corporation
13.6. GE Healthcare
13.7. Masimo Corporation
13.8. Medtronic PLC
13.9. Omron Corporation

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.